Literature DB >> 19732237

Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study.

Andrea Corrado1, Aldo Bonso, Michela Madalosso, Antonio Rossillo, Sakis Themistoclakis, Luigi Di Biase, Andrea Natale, Antonio Raviele.   

Abstract

BACKGROUND: Pulmonary veins (PVs) have been shown to represent the most frequent sites of ectopic beats initiating paroxysmal atrial fibrillation (AF). However, additional non-PV triggers, arising from different areas, have been reported as well. One of the most common non-PV sites described is the superior vena cava. AIMS: The purpose of the study was to investigate the impact resulting from the systematic isolation of the superior vena cava (SVCI) in addition to pulmonary vein antrum isolation (PVAI) on the outcome of paroxysmal, persistent, and permanent AF ablation.
METHODS: A total of 320 consecutive patients who had been referred to our center in order to undergo a first attempt of AF ablation were randomized into 2 groups. Group I (160 patients) underwent PVAI only; Group II (160 patients) underwent PVAI and SVCI.
RESULTS: AF was paroxysmal in 134 (46%), persistent in 75 (23%), and permanent in 111 (31%) of said patients. SVCI was performed on 134 of the 160 patients (84%) in Group II. SVC isolation was not performed on the remaining 26 patients either because of phrenic nerve capture or the lack of SVC potentials. Comparison of the outcome data between the 2 groups, after a follow-up of 12 months, revealed a significant difference in total procedural success solely with patients manifesting paroxysmal atrial fibrillation (56/73 [77%] Group I vs. 55/61 [90%] Group II; P = 0.04; OR 2.78).
CONCLUSIONS: In our study, the strategy of the empiric SVCI in addition to PVAI has improved the outcome of AF ablation solely in patients manifesting paroxysmal AF.

Entities:  

Mesh:

Year:  2009        PMID: 19732237     DOI: 10.1111/j.1540-8167.2009.01577.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  31 in total

1.  Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.

Authors:  Serge Sicouri; Jonathan Blazek; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-03-09

2.  Electrical isolation of the superior vena cava by laser balloon ablation in patients with atrial fibrillation.

Authors:  Martín R Arceluz; Pedro F Cruz; Estela Falconi; Rosa Montes de Oca; Reina Delgado; Jorge Figueroa; Marta Ortega; José L Merino
Journal:  J Interv Card Electrophysiol       Date:  2018-05-07       Impact factor: 1.900

3.  Atrial fibrillation: permanent isolation of the PV antrum begets cure.

Authors:  Pasquale Santangeli; Andrea Natale
Journal:  Nat Rev Cardiol       Date:  2011-03-01       Impact factor: 32.419

4.  Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis.

Authors:  Nazila Assasi; Feng Xie; Gord Blackhouse; Kathryn Gaebel; Diana Robertson; Rob Hopkins; Jeff S Healey; Ron Goeree
Journal:  J Interv Card Electrophysiol       Date:  2012-10-03       Impact factor: 1.900

5.  Structural relation between the superior vena cava and pulmonary veins in patients with atrial fibrillation.

Authors:  Kentaro Yoshida; Masako Baba; Hideyuki Hasebe; Yasutoshi Shinoda; Tomohiko Harunari; Mari Ebine; Yoshiko Uehara; Hiroaki Watabe; Noriyuki Takeyasu; Hitoshi Horigome; Akihiko Nogami; Masaki Ieda
Journal:  Heart Vessels       Date:  2019-05-22       Impact factor: 2.037

6.  Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up.

Authors:  Srijoy Mahapatra; Damien J LaPar; Sandeep Kamath; Jason Payne; Kenneth C Bilchick; James M Mangrum; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2011-06       Impact factor: 4.330

Review 7.  The role of empiric superior vena cava isolation in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sharan Prakash Sharma; Rajbir S Sangha; Khagendra Dahal; Parasuram Krishnamoorthy
Journal:  J Interv Card Electrophysiol       Date:  2016-10-14       Impact factor: 1.900

8.  Catheter Ablation of Atrial Fibrillation: Advent of Second-Generation Technologies.

Authors:  Eric Buch; Kalyanam Shivkumar
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

9.  Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF).

Authors:  Sanghamitra Mohanty; Amelia W Hall; Prasant Mohanty; Sameer Prakash; Chintan Trivedi; Luigi Di Biase; Pasquale Santangeli; Rong Bai; J David Burkhardt; G Joseph Gallinghouse; Rodney Horton; Javier E Sanchez; Patrick M Hranitzky; Amin Al-Ahmad; Vishwanath R Iyer; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2016-01       Impact factor: 1.900

10.  Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.

Authors:  Serge Sicouri; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2013-03-22       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.